Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China

We built a decision-analytic model to compare the cost-effectiveness of using portable spirometer and questionnaire to screen chronic obstructive pulmonary diseases (COPD) with no screening (i.e. usual care) among chronic bronchitis patient in China. A lifetime horizon and a payer perspective were a...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Shuli, You, Xuedan, Liu, Tianyi, Wang, Lijiao, Yin, Zheng, Liu, Yanjun, Ye, Chong, Yang, Ting, Huang, Mao, Li, Hongchao, Fang, Liwen, Zheng, Jinping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137942/
https://www.ncbi.nlm.nih.gov/pubmed/34016999
http://dx.doi.org/10.1038/s41533-021-00233-z
_version_ 1783695707046150144
author Qu, Shuli
You, Xuedan
Liu, Tianyi
Wang, Lijiao
Yin, Zheng
Liu, Yanjun
Ye, Chong
Yang, Ting
Huang, Mao
Li, Hongchao
Fang, Liwen
Zheng, Jinping
author_facet Qu, Shuli
You, Xuedan
Liu, Tianyi
Wang, Lijiao
Yin, Zheng
Liu, Yanjun
Ye, Chong
Yang, Ting
Huang, Mao
Li, Hongchao
Fang, Liwen
Zheng, Jinping
author_sort Qu, Shuli
collection PubMed
description We built a decision-analytic model to compare the cost-effectiveness of using portable spirometer and questionnaire to screen chronic obstructive pulmonary diseases (COPD) with no screening (i.e. usual care) among chronic bronchitis patient in China. A lifetime horizon and a payer perspective were adopted. Cost data of health services including spirometry screening and treatment costs covered both maintenance and exacerbation. The result indicated that portable spirometer screening was cost-saving compared with questionnaire screening and no screening, with an incremental cost-effectiveness ratio (ICER) of −5026 and −1766 per QALY, respectively. Sensitivity analyses confirmed the robustness of the results. In summary, portable spirometer screening is likely the optimal option for COPD screening among chronic bronchitis patients China.
format Online
Article
Text
id pubmed-8137942
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81379422021-06-03 Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China Qu, Shuli You, Xuedan Liu, Tianyi Wang, Lijiao Yin, Zheng Liu, Yanjun Ye, Chong Yang, Ting Huang, Mao Li, Hongchao Fang, Liwen Zheng, Jinping NPJ Prim Care Respir Med Article We built a decision-analytic model to compare the cost-effectiveness of using portable spirometer and questionnaire to screen chronic obstructive pulmonary diseases (COPD) with no screening (i.e. usual care) among chronic bronchitis patient in China. A lifetime horizon and a payer perspective were adopted. Cost data of health services including spirometry screening and treatment costs covered both maintenance and exacerbation. The result indicated that portable spirometer screening was cost-saving compared with questionnaire screening and no screening, with an incremental cost-effectiveness ratio (ICER) of −5026 and −1766 per QALY, respectively. Sensitivity analyses confirmed the robustness of the results. In summary, portable spirometer screening is likely the optimal option for COPD screening among chronic bronchitis patients China. Nature Publishing Group UK 2021-05-20 /pmc/articles/PMC8137942/ /pubmed/34016999 http://dx.doi.org/10.1038/s41533-021-00233-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Qu, Shuli
You, Xuedan
Liu, Tianyi
Wang, Lijiao
Yin, Zheng
Liu, Yanjun
Ye, Chong
Yang, Ting
Huang, Mao
Li, Hongchao
Fang, Liwen
Zheng, Jinping
Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
title Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
title_full Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
title_fullStr Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
title_full_unstemmed Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
title_short Cost-effectiveness analysis of COPD screening programs in primary care for high-risk patients in China
title_sort cost-effectiveness analysis of copd screening programs in primary care for high-risk patients in china
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137942/
https://www.ncbi.nlm.nih.gov/pubmed/34016999
http://dx.doi.org/10.1038/s41533-021-00233-z
work_keys_str_mv AT qushuli costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT youxuedan costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT liutianyi costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT wanglijiao costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT yinzheng costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT liuyanjun costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT yechong costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT yangting costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT huangmao costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT lihongchao costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT fangliwen costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina
AT zhengjinping costeffectivenessanalysisofcopdscreeningprogramsinprimarycareforhighriskpatientsinchina

Ejemplares similares